Novel technique helps surgeons to remove 'inoperable' abdominal tumors

NewsGuard 100/100 Score

Abdominal tumors involving both roots of the celiac and superior mesenteric artery (SMA) are deemed unresectable by conventional surgical methods, as removal would cause necrosis of the organs that are supplied by those blood vessels.

A case report published in the journal American Journal of Transplantation presents a novel surgical technique that enables surgeons to remove tumors that are unresectable by the usual surgical techniques.

Led by Tomoaki Kato, MD, FACS, of Columbia University, surgeons removed tumors in 3 patients involving both the celiac artery and SMA using new surgical techniques never performed before, known as "ex vivo" surgery where the organs are removed to do surgery.

First, surgeons removed entire abdominal organs together with the tumor. The patient is "organless" during this period. The tumor was cut and blood vessels were reconstructed using synthetic vascular grafts. Surgeons then re-implanted the organs back into the patient's abdomen, connecting blood vessels and gastrointestinal tracts.

Surgery was successful, and all 3 patients are alive with no tumor recurrence to date after 2 to 4 years from the surgery.

"Our technique appears both feasible and effective in the proper clinical situation when performed by a multidisciplinary team experienced in multivisceral transplantation," Kato notes. "This technique can expand the role of transplant surgery in specific oncological problem, and more patients with 'inoperable' tumors can be operated."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lactate's role in driving cancer cachexia uncovered